SHE:300122 Market Cap

SHE:300122 has a market cap or net worth of 38.71 billion as of March 9, 2026. Its market cap has decreased by -37.35% in one year.

Market Cap

38.71B

Enterprise Value

50.58B

Revenue

10.91B

Ranking

n/a

PE Ratio

n/a

Stock Price

16.17

Market Cap Chart

Since September 28, 2010, SHE:300122's market cap has increased from 15.42B to 38.71B, an increase of 151.02%. That is a compound annual growth rate of 6.14%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	38.71B	-14.31%
Dec 31, 2025	45.17B	-28.25%
Dec 31, 2024	62.96B	-57.07%
Dec 29, 2023	146.66B	4.37%
Dec 30, 2022	140.53B	-29.51%
Dec 31, 2021	199.36B	-15.76%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hebei Changshan Biochemical Pharmaceutical	39.43B
Shanghai RAAS Blood Products	41.21B
Sunshine Guojian Pharmaceutical (Shanghai)	35.97B
Asymchem Laboratories (Tianjin)	35.00B
Shanghai Allist Pharmaceuticals	43.80B
Pharmaron Beijing	46.31B
Beijing Tiantan Biological Products	31.40B
Beijing Wantai Biological Pharmacy Enterprise	49.56B

Market Cap Rankings